肝细胞癌18F-FDG PET的SUVmax与PD-L1表达的关系
本回顾性研究纳入102例确诊肝细胞癌患者,用免疫组化检测肿瘤PD-L1表达与免疫细胞浸润,用18F-FDG PET/CT评估病灶SUVmax。结果显示肝癌FDG摄取与PD-L1表达及细胞毒性T细胞、M2巨噬细胞浸润数量正相关;联合SUVmax与门静脉癌栓可更好地评估PD-L1表达。
要点
- 低分化、大肿瘤、门静脉癌栓、淋巴结或远处转移及死亡患者肝癌原发灶SUVmax更高。
- 肝癌FDG摄取与PD-L1表达及细胞毒性T细胞、M2巨噬细胞浸润数量正相关。
- 联合SUVmax与门静脉癌栓的PET/CT评估可更好地判断肝癌PD-L1表达。
核心结论
- 肝癌FDG摄取与PD-L1表达及细胞毒性T细胞、M2巨噬细胞浸润数量呈正相关。
- 联合SUVmax与门静脉癌栓的PET/CT影像评估能更好地评估肝癌PD-L1表达。
- 这些发现为通过PET/CT评估肿瘤免疫状态的临床研究提供了依据。
研究设计与样本
- 本研究为回顾性研究,共纳入102例确诊肝细胞癌患者。
- 通过免疫组化染色测定肿瘤PD-L1表达与免疫细胞浸润。
- 使用18F-FDG PET/CT评估肝癌病灶的SUVmax。
- 采用Cox比例风险模型与Kaplan-Meier生存分析评估PD-L1表达与临床病理特征的相关性。
主要发现
- 肝癌原发灶SUVmax在低分化、大肿瘤、门静脉癌栓、淋巴结和远处转移及死亡患者中更高。
- 肝癌SUVmax与PD-L1表达及细胞毒性T细胞、M2巨噬细胞浸润数量相关。
- PD-L1表达与肿瘤SUVmax、肿瘤分化、肿瘤大小、门静脉癌栓、患者生存状态及浸润M2巨噬细胞显著相关。
- 多因素分析证实SUVmax、门静脉癌栓和浸润M2巨噬细胞数量与PD-L1表达密切相关,为独立危险因素。
- 联合SUVmax值与门静脉癌栓的18F-FDG PET/CT影像评估有助于判断肝癌PD-L1表达。
临床怎么用
- 作者认为,联合SUVmax与门静脉癌栓的PET/CT影像评估可更好地评估肝癌PD-L1表达。
- 作者指出,这些发现为通过PET/CT评估肿瘤免疫状态的临床研究提供了依据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Our study was to investigate the correlation between 18F-FDG uptake in HCC and tumor PD-L1 expression in HCC, and assess the value of 18F-FDG PET/CT imaging for predicting PD-L1 expression in HCC. METHODS: A total of 102 patients with confirmed HCC were included in this retrospective study. The PD-L1 expression and immune cell infiltrating of tumors were determined through immunohistochemistry staining. The SUVmax of HCC lesions were assessed using 18F-FDG PET/CT. The correlation between PD-L1 expression and the clinicopathological were evaluated by the Cox proportional hazards model and the Kaplan-Meier survival analysis. RESULTS: The SUVmax of HCC primary tumors was higher in patients with poorly differentiated HCC, large tumor size, portal vein tumor thrombus, lymph node and distant metastases, and death. The SUVmax of HCC are correlated with the PD-L1 expression and the number of cytotoxic T cells and M2 macrophage infiltration. PD-L1 expression was significantly correlated with tumor SUVmax, tumor differentiation, tumor size, portal vein tumor thrombosis, and patient survival status and infiltrating M2 macrophages. Further, our results confirmed that SUVmax, portal vein tumor thrombosis, and the number of infiltrating M2 macrophages were closely related to PD-L1 expression and were independent risk factors by multivariate analysis. The combined assessment of SUVmax values and the presence of portal vein tumor thrombosis by 18F-FDG PET/CT imaging can help determine PD-L1 expression in HCC. CONCLUSIONS: FDG uptake in HCC was positively correlated with the PD-L1 expression and the number of cytotoxic T cells and M2 macrophage infiltration. The combined use of SUVmax and portal vein tumor thrombosis by PET/CT imaging assess the PD-L1 expression better in HCC. These findings also provide a basis for clinical studies to assess the immune status of tumors by PET/CT.
引用
- Zhou X, Hu Y, Sun H, et al. Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2023. PMID: 37147479. doi:10.1007/s00259-023-06251-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。